These GLP-1 receptor agonists can be categorized as either short-acting compounds, which provide short-lived receptor activation (such as exenatide and lixisenatide) or as long-acting compounds (for example albiglutide, dulaglutide, exenatide long-acting release, and liraglutide), which activate the GLP-1 receptor continuously at their recommended dose
But that doesnt mean other high-level physicians and biohackers have ignored its positive yet powerful effects on body recomposition
GLP-1 medications including semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) have helped many people manage their weight and improve their health
Neurochem Res 45(7):14611480 Nikolova S, Schwedt TJ (2022) Magnetic resonance spectroscopy studies in migraine
While not FDA-approved specifically for fatty liver disease, emerging evidence suggests Zepbound may help reduce liver fat and inflammation through substantial weight loss and improved metabolic function